Target intelligence / Profile preview

Integrin alphaVbeta8 (αvβ8)

Target
αvβ8
Molecular classification
Integrin, Receptor, Transmembrane receptor
01

Overview

Integrin alphaVbeta8 (αvβ8) is a heterodimeric transmembrane receptor composed of the αv (ITGAV) and β8 (ITGB8) subunits. It belongs to the αv integrin subfamily. Unlike most other integrins, β8 is unique in both structure and function. It primarily binds latent TGF-beta complexes, activating TGF-beta signaling. αvβ8 is expressed in various tissues and plays a role in cell-cell interactions, neurodevelopment, fibrosis and cancer. Antagonists are being developed to block pathological TGF-beta activation in diseases such as cancer.

Other names
alphaVbeta8 integrinITGAV/ITGB8 heterodimer
02

Mechanism of action

Antagonists targeting αvβ8 block pathological TGF-beta activation.

03

Biological functions

Cell-cell communicationTGF-beta activationECM binding
04

Disease associations

NeurodegenerationFibrosisCancer progressionImmunosuppression
05

Safety considerations

Potential for broad TGF-beta pathway modulation leading to unforeseen consequences.Off-target effects due to RGD-motif binding promiscuity to other integrins.

Beyond the preview

Go deeper on Integrin alphaVbeta8 (αvβ8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin alphaVbeta8 (αvβ8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call